- CA$18.84m
- CA$18.84m
- 28
- 20
- 56
- 26
Annual income statement for Cheelcare, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Total Operating Expenses | 0.008 | 0.12 | 0.044 | 0.066 |
| Operating Profit | -0.008 | -0.12 | -0.044 | -0.066 |
| Net Income Before Taxes | -0.008 | -0.12 | -0.044 | -0.066 |
| Net Income After Taxes | -0.008 | -0.12 | -0.044 | -0.066 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.008 | -0.12 | -0.044 | -0.066 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.008 | -0.12 | -0.044 | -0.066 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.005 | -0.08 | -0.029 | -0.044 |